196 related articles for article (PubMed ID: 3983831)
21. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
22. Calcium and phosphorus metabolism in maintenance hemodialysis.
Ritz E; Mehls O; Krempien B
Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
[No Abstract] [Full Text] [Related]
23. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
[TBL] [Abstract][Full Text] [Related]
24. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
25. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
26. Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
Sato Y; Eriguchi R; Umakoshi J; Kato M
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S48-53. PubMed ID: 17976086
[TBL] [Abstract][Full Text] [Related]
27. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
[TBL] [Abstract][Full Text] [Related]
28. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
[TBL] [Abstract][Full Text] [Related]
29. [Parathyrin and calcitonin in patients with chronic renal insufficiency].
Dzhavad-Zade MD; Agaev MM; Karaev ME
Med Radiol (Mosk); 1985 Dec; 30(12):47-9. PubMed ID: 4079692
[TBL] [Abstract][Full Text] [Related]
30. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
[TBL] [Abstract][Full Text] [Related]
31. [Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():68-71. PubMed ID: 16898492
[TBL] [Abstract][Full Text] [Related]
32. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
33. [Diurnal changes in the levels of immunoreactive parathyroid hormone and calcitonin in patients with chronic renal insufficiency].
Ivić MA; Bogićević M; Djordjević V; Mitić M; Stefanović V
Srp Arh Celok Lek; 1992; 120(5-6):141-5. PubMed ID: 1465667
[TBL] [Abstract][Full Text] [Related]
34. Changes in serum phosphorus, calcium and alkaline phosphatase due to sucralfate.
Vucelić B; Hadzić N; Gragas J; Puretić Z
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):93-6. PubMed ID: 3514490
[TBL] [Abstract][Full Text] [Related]
35. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
Cundy T; Heynen G; Paton S; Ledingham JG; Russell RG; Oliver DO; Kanis JA
Proc Eur Dial Transplant Assoc; 1978; 15():524-31. PubMed ID: 740683
[TBL] [Abstract][Full Text] [Related]
36. [Gastric acid secretion and calcium metabolism in patients with chronic hemodialysis].
Fendler JP; Khazine F; Dongradi G; Cassan P; Beaugrand M; Salmon D
J Urol Nephrol (Paris); 1978 Sep; 84(9):658-63. PubMed ID: 748587
[No Abstract] [Full Text] [Related]
37. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
[No Abstract] [Full Text] [Related]
38. [Postburn changes in serum levels of calcitonin, parathyroid hormone and 25-hydroxycholecalciferol].
Xue Y
Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):555-9, 38. PubMed ID: 2620263
[TBL] [Abstract][Full Text] [Related]
39. PTH bioactivity in osteoporosis.
Saphier PW; Stamp TC; Kelsey CR; Loveridge N
Bone Miner; 1987 Oct; 3(1):75-83. PubMed ID: 3505195
[TBL] [Abstract][Full Text] [Related]
40. [Changes in phosphorus-calcium metabolism in experimental renal insufficiency and after administration of dihydrotachysterol and thyrocalcitonin].
Migunova NA; Ermolenko VM; Nikiforova NV; Malinina NV; Blazheevich NV
Vopr Med Khim; 1976; 22(3):400-6. PubMed ID: 1030898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
